Effectiveness of intraoral stents in reducing oral adverse events during radiotherapy for maxillary or nasal cavity malignant tumors.
Mao KawakamiNobuhiro UedaKaori YamakiKumiko AokiNobuhide WakaiTetsuro TamamotoIsao AsakawaTadaaki KiritaPublished in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2024)
Our findings suggest that the use of an IOS during RT reduces the severity of OM by reducing irradiation to the tongue. Therefore, the use of an IOS is recommended during RT performed in the maxilla or nasal cavity.